Lenalidomide following stem cell transplant can halt progression of blood cancer News-Medical.net Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid-, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science ... |
